|A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma||
||270||All||18 Years and older (Adult, Senior)||NCT00111007||11718
|May 2005||September 2006||January 2009||May 17, 2005||October 31, 2014||February 23, 2011||
|2||NCT02583516||Recruiting||Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma||
||Other / Industry||
||116||All||18 Years and older (Adult, Senior)||NCT02583516||GEM-01-15
|June 2015||December 2018||December 2018||October 22, 2015||August 23, 2016||
† Study has passed its completion date and status has not been verified in more than two years.